Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04046900 · ClinicalTrials.gov registry record · Phase 1
Vaginal Microbiota Transplant
A Phase 1 study of Recurrent Bacterial Vaginosis, sponsored by Douglas Kwon.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 62
- Enrollment target
- 1
- Study location
NCT04046900 is a Phase 1 study of Recurrent Bacterial Vaginosis that is actively recruiting participants, run by Douglas Kwon. The registered enrollment target is 62 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04046900, a Phase 1 study of Recurrent Bacterial Vaginosis, is actively recruiting participants, sponsored by Douglas Kwon.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized trial of vaginal microbiome transplant vs. saline placebo to restore a Lactobacillus dominant vaginal microbial community in women with recurrent bacterial vaginosis.
Conditions Studied
Interventions
- BIOLOGICAL Vaginal microbiome transplant
- DRUG Oral Metronidazole
- OTHER Sterile saline
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2021-04-22 |
| Est. Completion | 2026-09-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04046900
The ClinicalTrials.gov registry entry for NCT04046900 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Douglas Kwon, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Recurrent Bacterial Vaginosis appearing as the primary indexed condition, and to 3 interventions - of which Vaginal microbiome transplant is the first listed.
NCT04046900 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04046900 about?
NCT04046900 is a clinical study titled "Vaginal Microbiota Transplant". This is a randomized trial of vaginal microbiome transplant vs. saline placebo to restore a Lactobacillus dominant vaginal microbial community in women with recurrent bacterial vaginosis.
What is the current status of trial NCT04046900?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 62 participants. The study started on 2021-04-22. Estimated completion is 2026-09-30.
What conditions does trial NCT04046900 study?
This clinical trial studies the following conditions: Recurrent Bacterial Vaginosis.
What interventions are being tested in trial NCT04046900?
The interventions under investigation include: Vaginal microbiome transplant (BIOLOGICAL), Oral Metronidazole (DRUG), Sterile saline (OTHER).
Who is sponsoring clinical trial NCT04046900?
This trial is sponsored by Douglas Kwon, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04046900 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.